Bristol-Myers Squibb Company (BMY) Analyst Forecast

$63.15

north_east
$2.06 (3.37%)
Day's range
$60.72
Day's range
$63.15

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/12/2024 BMO Capital Evan Seigerman $61.00 $56.23   8.49%
11/01/2024 BMO Capital Evan David Seigerman $57.00 $54.32   4.93%
09/23/2024 BMO Capital Evan David Seigerman $48.00 $49.56   -3.15%
07/29/2024 Goldman Sachs Chris Shibutani $57.00 $50.55   12.77%
07/29/2024 Barclays Carter Gould $41.00 $50.45   -18.73%
07/12/2024 UBS Trung Huynh $43.00 $40.68   5.7%
05/16/2024 Cowen & Co. Steve Scala $67.00 $44.11   51.89%
01/30/2024 Deutsche Bank James Shin $55.00 $49.87   10.29%
11/27/2023 BMO Capital Evan Seigerman $60.00 $49.76   20.58%
10/12/2023 Leerink Partners David Risinger $66.00 $56.25   17.34%
09/06/2023 Cantor Fitzgerald Louise Chen $75.00 $59.67   25.69%
05/02/2022 Guggenheim Seamus Fernandez $80.00 $75.27   6.28%
05/01/2022 BMO Capital Evan Seigerman $87.00 $75.08   15.88%
10/27/2021 Barclays Carter Gould $66.00 $56.22   17.4%
10/24/2021 Citigroup Andrew Baum $75.00 $56.89   31.83%
09/19/2021 Guggenheim Seamus Fernandez $82.00 $59.05   38.87%
09/06/2021 Societe Generale Justin Smith $85.00 $63.63   33.58%
07/26/2021 Bank of America Securities Geoff Meacham $78.00 $65.88   18.4%

Bristol-Myers Squibb Company FAQ's

Bristol-Myers Squibb Company has been rated by research analysts at BMO Capital, Goldman Sachs, Barclays, UBS, Cowen & Co., Deutsche Bank in the past 90 days.